It most certainly is a challenge. For the most par
Post# of 30028
Posted On: 02/04/2015 12:23:51 PM
Re: Daveludlow #16294
It most certainly is a challenge. For the most part, I think many of the longs on this board have been very patient and willing to give Gerald and his team time to develop the pipeline and add talent. IMO, they have done a tremendous job doing those those things over the past couple years.
Now, I think there's got to be a laser-like focus on monetizing one of these assets real soon. This would not only reward shareholders who have stood by the company for quite some time, but it would also gain tremendous credibility from the market who will need to see a deal that validates this business model.
I sense that many people will be watching next week's presentation. I hope we're able to take advantage of this big stage and come out of the conference with some serious momentum.
Now, I think there's got to be a laser-like focus on monetizing one of these assets real soon. This would not only reward shareholders who have stood by the company for quite some time, but it would also gain tremendous credibility from the market who will need to see a deal that validates this business model.
I sense that many people will be watching next week's presentation. I hope we're able to take advantage of this big stage and come out of the conference with some serious momentum.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼